Markus Aly

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: ACTA ANAESTHESIOLOGICA SCANDINAVICA. 2024;68(8):1006-1015
Postoperative pain, recovery and discharge after robot-assisted laparoscopic prostatectomy: A multicentre, single blinded, randomised controlled trial
Hallengren S; Schening A; Lindstrom A-C; Radros J; Eriksson J; Blomqvist E; Knutas R; Fallman N; Aly M; Gupta A
Article: BJUI COMPASS. 2024;5(9):999-1006
Long-term oncological outcomes after multimodal treatment for locally advanced prostate cancer
Roldan FL; Falagario UG; Olsson M; Salas RS; Aly M; Egevad L; Lantz A; Gronberg H; Akre O; Hosseini A; Wiklund NP
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2024;116(9):1459-1465
Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonists
Bjornebo L; Razdan S; Discacciati A; Palsdottir T; Aly M; Nordstrom T; Eklund M; Lundon D; Gronberg H; Tewari A; Wiklund P; Kyprianou N; Lantz A
Article: EUROPEAN UROLOGY ONCOLOGY. 2024;7(4):888-896
Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years Report from the EAU Robotic Urology Section Scientific Working Group '
Pellegrino F; Falagario UG; Knipper S; Martini A; Akre O; Egevad L; Aly M; Moschovas MC; Bravi CA; Tran J; Heiniger Y; von Kempis A; Schaffar R; Carrieri G; Briganti A; Montorsi F; Rochat C-H; Mottrie A; Ahlering TE; John H; Patel V; Graefen M; Wiklund P
Article: BMC CANCER. 2024;24(1):891
Effects of an exercise intervention in primary care after robot-assisted radical cystectomy for urinary bladder cancer: a randomised controlled trial
Porserud A; Karlsson P; Aly M; Rydwik E; Torikka S; Henningsohn L; Nygren-Bonnier M; Hagstromer M
Journal article: INVESTIGATIVE UROLOGY. 2024;211(5S):e219
MP14-02 IDENTIFY THE OPTIMAL CANDIDATES FOR ADJUVANT ANDROGEN DEPRIVATION THERAPY AMONG PATIENTS WITH DETECTABLE PSA AFTER RADICAL PROSTATECTOMY
Pellegrino F; Falagario UG; Knipper S; Martini A; Akre O; Aly M; Moschovas MC; Bravi CA; Tran J; Heiniger Y; von Kempis A; Schaffar R; Carrieri G; Briganti A; Montorsi F; Rochat C-H; Mottrie A; Ahlering TE; John H; Patel V; Graefen M; Wiklund P
Journal article: INVESTIGATIVE UROLOGY. 2024;211(5S):e969
PD45-06 ACCURACY OF THE MRI 5-POINT LIKERT SCORE TO PREDICT EXTRA-PROSTATIC EXTENSION AND SEMINAL VESICLE INVASION IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER AND DEVELOPMENT OF a NEW MRI-BASED NOMOGRAM
Pellegrino F; Falagario UG; Proietti F; Brasetti A; Hagman A; Briganti A; Montorsi F; Carrieri G; Lantz A; Akre O; Aly M; Egevad L; Jaderling F; Wiklund P
Journal article: INVESTIGATIVE UROLOGY. 2024;211(5S):e1213
PD57-12 PSA RESPONSE AFTER RADIOTHERAPY. IS THERE A DEFINITION OF PSA PERSISTENCE AFTER RT?
Falagario UG; Pellegrino F; Abbadi A; Björnebo L; Valdman A; Carrieri GG; Briganti A; Montorsi F; Akre O; Aly M; Eklund M; Nordström T; Grönberg H; Wiklund P; Lantz A
Journal article: INVESTIGATIVE UROLOGY. 2024;211(5S):e623
PD29-12 THE IMPACT OF THE TIME ELAPSED BETWEEN PRIMARY TREATMENT AND BCR ON CANCER SPECIFIC MORTALITY IN PATIENTS WHO EXPERIENCED BCR AFTER PRIMARY TREATMENT
Pellegrino F; Falagario UG; Abbadi A; Björnebo L; Valdman A; Carrieri G; Briganti A; Montorsi F; Akre O; Aly M; Eklund M; Nordström T; Grönberg H; Lantz A; Wiklund P
Journal article: EUROPEAN UROLOGY. 2024;85:s1404-s1405
Identify the optimal candidates for adjuvant androgen deprivation therapy among patients with detectable PSA after radical prostatectomy
Pellegrino F; Falagario UG; Knipper S; Martini A; Akre O; Aly M; Moschovas MC; Bravi CA; Tran J; Heiniger Y; Von Kempis A; Schaffar R; Carrieri G; Briganti A; Montorsi F; Rochat C-H; Mottrie A; Ahlering TE; John H; Patel V; Graefen M; Wiklund P
Journal article: EUROPEAN UROLOGY. 2024;85:s1401
Time to death and clinical characteristics of patients who died for prostate cancer after robot-assisted radical prostatectomy: 20 years' report from the EAU Robotic Urology Section (ERUS) scientific working group
Falagario UG; Pellegrino F; Moschovas MC; Knipper S; Martini A; Akre O; Egevad L; Aly M; Bravi CA; Tran J; Heiniger Y; Von Kempis A; Schaffar R; Carrieri G; Briganti A; Montorsi F; Rochat C-H; Mottrie A; Ahlering TE; John H; Patel V; Graefen M; Wiklund P
Journal article: EUROPEAN UROLOGY. 2024;85:s334-s335
The risk of venous thromboembolic events in men operated with laparoscopic or open radical prostatectomy - a nationwide population-based cohort study
Bjorklund J; Rautiola J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Article: ANNALS OF SURGICAL ONCOLOGY. 2024;31(3):1789-1790
ASO Author Reflections: Arterial Ischemic Events Following Cancer Surgery: Where Do We Stand?
Rautiola J; Bjoerklund J; Zelic R; Edgren G; Bottai M; Nilsson M; Vincent PH; Fredholm H; Falconer H; Sjovall A; Nilsson PJ; Wiklund P; Aly M; Akre O
Article: ANNALS OF SURGICAL ONCOLOGY. 2024;31(2):1739-1748
Risk of Postoperative Ischemic Stroke and Myocardial Infarction in Patients Operated for Cancer
Rautiola J; Bjoerklund J; Zelic R; Edgren G; Bottai M; Nilsson M; Vincent PH; Fredholm H; Falconer H; Sjovall A; Nilsson PJ; Wiklund P; Aly M; Akre O
Journal article: EUROPEAN UROLOGY. 2024;85:s1402-s1403
PSA response after radiotherapy. Is there a definition of PSA persistence after RT?
Falagario UG; Pellegrino F; Abbadi A; Bjornebo L; Valdman A; Carrieri G; Briganti A; Montorsi F; Akre O; Aly M; Eklund M; Nordstrom T; Gronberg H; Wiklund P; Lantz A
Journal article: EUROPEAN UROLOGY. 2024;85:s1534-s1535
The impact of the time elapsed between primary treatment and BCR on cancer specific mortality in patients who experienced BCR after primary treatment
Pellegrino F; Falagario UG; Abbadi A; Bjornebo L; Valdman A; Carrieri G; Briganti A; Montorsi F; Akre O; Aly M; Eklund M; Nordstrom T; Gronberg H; Lantz A; Wiklund P
Journal article: EUROPEAN UROLOGY. 2024;85:s459-s460
Accuracy of the MRI 5-point Likert score to predict extra-prostatic extension and seminal vesicle invasion in patients undergoing radical prostatectomy for prostate cancer and development of a new MRI-based nomogram.
Pellegrino F; Falagario UG; Proietti F; Brasetti A; Hagman A; Briganti A; Montorsi F; Carrieri G; Lantz A; Akre O; Aly M; Egevad L; Jaderling F; Wiklund P
Article: JAMA NETWORK OPEN. 2024;7(2):e2354352
Risk of Venous Thromboembolic Events After Surgery for Cancer
Bjorklund J; Rautiola J; Zelic R; Edgren G; Bottai M; Nilsson M; Vincent PH; Fredholm H; Falconer H; Sjoevall A; Nilsson PJ; Wiklund P; Aly M; Akre O
Article: PILOT AND FEASIBILITY STUDIES. 2024;10(1):12
The feasibility of an exercise intervention after robotic-assisted radical cystectomy for urinary bladder cancer, prior to the CanMoRe trial
Porserud A; Karlsson P; Nygren-Bonnier M; Aly M; Hagstromer M
Article: NATURE GENETICS. 2023;55(12):2065-2074
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
Wang A; Shen J; Rodriguez AA; Saunders EJ; Chen F; Janivara R; Darst BF; Sheng X; Xu Y; Chou AJ; Benlloch S; Dadaev T; Brook MN; Plym A; Sahimi A; Hoffman TJ; Takahashi A; Matsuda K; Momozawa Y; Fujita M; Laisk T; Figueredo J; Muir K; Ito S; Liu X; Uchio Y; Kubo M; Kamatani Y; Lophatananon A; Wan P; Andrews C; Lori A; Choudhury PP; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Giles GG; Southey MC; MacInnis RJ; Cybulski C; Wokolorczyk D; Lubinski J; Rentsch CT; Cho K; Mcmahon BH; Neal DE; Donovan JL; Hamdy FC; Martin RM; Nordestgaard BG; Nielsen SF; Weischer M; Bojesen SE; Roder A; Stroomberg HV; Batra J; Chambers S; Horvath L; Clements JA; Tilly W; Risbridger GP; Gronberg H; Aly M; Szulkin R; Eklund M; Nordstrom T; Pashayan N; Dunning AM; Ghoussaini M; Travis RC; Key TJ; Riboli E; Park JY; Sellers TA; Lin H-Y; Albanes D; Weinstein S; Cook MB; Mucci LA; Giovannucci E; Lindstrom S; Kraft P; Hunter DJ; Penney KL; Turman C; Tangen CM; Goodman PJ; Thompson IMJ; Hamilton RJ; Fleshner NE; Finelli A; Parent M-E; Stanford JL; Ostrander EA; Koutros S; Freeman LEB; Stampfer M; Wolk A; Hakansson N; Andriole GL; Hoover RN; Machiela MJ; Sorensen KD; Borre M; Blot WJ; Zheng W; Yeboah ED; Mensah JE; Lu Y-J; Zhang H-W; Feng N; Mao X; Wu Y; Zhao S-C; Sun Z; Thibodeau SN; McDonnell SK; Schaid DJ; West CML; Barnett G; Maier C; Schnoeller T; Luedeke M; Kibel AS; Drake BF; Cussenot O; Cancel-Tassin G; Menegaux F; Truong T; Koudou YA; John EM; Grindedal EM; Maehle L; Khaw K-T; Ingles SA; Stern MC; Vega A; Gomez-Caamano A; Fachal L; Rosenstein BS; Kerns SL; Ostrer H; Teixeira MR; Paulo P; Brandao A; Watya S; Lubwama A; Bensen JT; Butler EN; Mohler JL; Taylor JA; Kogevinas M; Dierssen-Sotos T; Castano-Vinyals G; Cannon-Albright L; Teerlink CC; Huff CD; Pilie P; Yu Y; Bohlender RJ; Gu J; Strom SS; Multigner L; Blanchet P; Brureau L; Kaneva R; Slavov C; Mitev V; Leach RJ; Brenner H; Chen X; Holleczek B; Schoettker B; Klein EA; Hsing AW; Kittles RA; Murphy AB; Logothetis CJ; Kim J; Neuhausen SL; Steele L; Ding YC; Isaacs WB; Nemesure B; Hennis AJM; Carpten J; Pandha H; Michael A; De Ruyck K; De Meerleer G; Ost P; Xu J; Razack A; Lim J; Teo S-H; Newcomb LF; Lin DW; Fowke JH; Neslund-Dudas CM; Rybicki BA; Gamulin M; Lessel D; Kulis T; Usmani N; Abraham A; Singhal S; Parliament M; Claessens F; Joniau S; Van den Broeck T; Gago-Dominguez M; Castelao JE; Martinez ME; Larkin S; Townsend PA; Aukim-Hastie C; Bush WS; Aldrich MC; Crawford DC; Srivastava S; Cullen J; Petrovics G; Casey G; Wang Y; Tettey Y; Lachance J; Tang W; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Yamoah K; Govindasami K; Chokkalingam AP; Keaton JM; Hellwege JN; Clark PE; Jalloh M; Gueye SM; Niang L; Ogunbiyi O; Shittu O; Amodu O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Diop H; Gundell SM; Roobol MJ; Jenster G; van Schaik RHN; Hu JJ; Sanderson M; Kachuri L; Varma R; McKean-Cowdin R; Torres M; Preuss MH; Loos RJF; Zawistowski M; Zollner S; Lu Z; Van Den Eeden SK; Easton DF; Ambs S; Edwards TL; Magi R; Rebbeck TR; Fritsche L; Chanock SJ; Berndt SI; Wiklund F; Nakagawa H; Witte JS; Gaziano JM; Justice AC; Mancuso N; Terao C; Eeles RA; Kote-Jarai Z; Madduri RK; Conti DV; Haiman CA
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2023;57:s104-s105
P069 PSA persistence after prostatectomy – prognosis and the effect of adjuvant radiotherapy
Möller A; Nordström T; Eklund M; Akre O; Egevad L; Aly M
Journal article: ANNALS OF ONCOLOGY. 2023;34:s1217
Correlation between overall survival and bladder-intact event-free survival in cystectomy-ineligible/refusal muscleinvasive bladder cancer patients in Sweden
Kwok KH; Laurin O; Baculea S; Cote S; Spigelman S; Szulkin R; Schain F; Jones CV; Aly M
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2023;55:s84
PE041 The impact of lymph-node dissection during radical prostatectomy on the risk of venous thromboembolic complications – a population-based study
Rautiola J; Björklund J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Article: EJSO. 2023;49(9):106943
Association between early mobilisation after abdominal cancer surgery and postoperative complications
Porserud A; Aly M; Nygren-Bonnier M; Hagstromer M
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2023;51:89-94
Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer
Lantz A; Nordlund P; Falagario U; Joderling F; Ozbek O; Clements M; Discacciati A; Gronberg H; Eklund M; Stricker P; Emberton M; Aly M; Nordstrom T
Journal article: INVESTIGATIVE UROLOGY. 2023;209(Supplement 4):e997
PD38-11 THE STOCKHOLM3 PROSTATE CANCER SCREENING TRIAL (STHLM3): AN INTERIM ANALYSIS OF MORTALITY RESULTS AFTER 6.5 YEARS OF FOLLOW-UP
Micoli C; Crippa A; Discacciati A; Palsdottir T; Vigneswaran H; Aly M; Adolfsson J; Lindberg J; Wiklund P; Thompson J; Brandberg Y; Clements M; Egevad L; Grönberg H; Nordström T; Eklund M
Journal article: INVESTIGATIVE UROLOGY. 2023;209(Supplement 4):e419
PD15-04 PREDICTION OF PROSTATE CANCER SPECIFIC MORTALITY IN MEN UNDERGOING RADIOTHERAPY WITH OR WITHOUT HORMONAL TREATMENT, RISK STRATIFICATION BASED ON CLINICAL CHARACTERISTICS AND PSA TREATMENT RESPONSE
Falagario U; Bogdanovic D; Björnebo L; Abbadi A; Valdman A; Eklund M; Nordström T; Aly M; Grönberg H; Wiklund P; Lantz A
Journal article: INVESTIGATIVE UROLOGY. 2023;209(Supplement 4):e214
MP17-06 VALIDATION OF EAU RISK GROUPS FOR BIOCHEMICAL RECURRENCE AFTER RADIOTHERAPY AND RADICAL PROSTATECTOMY FOR PREDICTION OF PROSTATE CANCER MORTALITY
Falagario U; Bogdanovic D; Björnebo L; Abbadi A; Valdman A; Eklund M; Nordström T; Aly M; Grönberg H; Lantz A; Wiklund P
Journal article: EUROPEAN UROLOGY. 2023;83:s371
A0261 The risk of ischemic stroke and myocardial infarction in prostate cancer patients treated with radical prostatectomy – population-based nationwide matched cohort study
Rautiola J; Björklund J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Journal article: EUROPEAN UROLOGY. 2023;83:s369-s370
A0260 The risk of venous thromboembolic events among men operated with radical prostatectomy - A nationwide population-based cohort study
Björklund J; Rautiola J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Journal article: EUROPEAN UROLOGY. 2023;83:s209-s210
A0152 The risk of Venous thromboembolic events in patients operated with radical cystectomy - a nationwide population-based cohort study
Björklund J; Rautiola J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Journal article: EUROPEAN UROLOGY. 2023;83:s208
A0151 The risk of arterial thromboembolic complications in bladder cancer patients after radical cystectomy – population-based nationwide matched cohort study
Rautiola J; Björklund J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Journal article: EUROPEAN UROLOGY. 2023;83:s1266-s1267
The Stockholm3 prostate cancer screening trial (STHLM3): An interim analysis of mortality results after 6.5 years of follow-up
Micoli C; Crippa A; Discacciati A; Vigneswaran H; Palsdottir T; Clements M; Aly M; Adolfsson J; Fredrik W; Wiklund P; James T; Lindberg J; Gronberg H; Egevad L; Nordstrom T; Eklund M
Journal article: EUROPEAN UROLOGY. 2023;83:s1613-s1614
Prediction of prostate cancer specific mortality in men undergoing radiotherapy with or without hormonal treatment, risk stratification based on clinical characteristics and PSA treatment response
Falagario UG; Bogdanovic D; Bjornebo L; Abbadi A; Valdman A; Eklund M; Nordstrom T; Aly M; Gronberg H; Wiklund P; Lantz A
Journal article: EUROPEAN UROLOGY. 2023;83:s379-s380
A0266 Validation of EAU Risk groups for biochemical recurrence after radiotherapy and radical prostatectomy for prediction of prostate cancer mortality
Falagario UG; Bogdanovic D; Björnebo L; Abbadi A; Valdman A; Eklund M; Nordström T; Aly M; Grönberg H; Lantz A; Wiklund P
Article: ACTA ONCOLOGICA. 2022;61(11):1377-1385
Cardiovascular, bone, and metabolic health in men with castrate-resistant prostate cancer treated with androgen deprivation: a matched cohort study
Khoshkar Y; Vigneswaran HTT; Eloranta S; Andersson TM-L; Schain F; Boman A; Dahlkild M; Liwing J; Leval A; Akre O; Aly M
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;44:46-51
Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data
Ventimiglia E; Bill-Axelson A; Adolfsson J; Aly M; Eklund M; Westerberg M; Stattin P; Garmo H
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;44:69-75
Digital Rectal Examination in Stockholm3 Biomarker-based Prostate Cancer Screening
Andersson J; Palsdottir T; Lantz A; Aly M; Gronberg H; Egevad L; Eklund M; Nordstrom T
Article: JAMA ONCOLOGY. 2022;8(7):1019-1026
Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality
Bjornebo L; Nordstrom T; Discacciati A; Palsdottir T; Aly M; Gronberg H; Eklund M; Lantz A
Article: VACCINE. 2022;40(27):3797-3801
Travel vaccines are strongly associated to reduced mortality in prostate cancer patients-a real effect or residual confounding?
Moeller A; Schwamborn K; Spillmann A; Hoogstraate J; Szulkin R; Akre O; Egevad L; Clements M; Aly M
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2022;56(3):169-175
Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists
Bonde TM; Westerberg M; Aly M; Eklund M; Adolfsson J; Bill-Axelson A; Garmo H; Stattin P; Robinson D
Journal article: INVESTIGATIVE UROLOGY. 2022;207(Supplement 5):e255
PD13-11 DISEASE TRAJECTORIES AND OUTCOMES FOR MEN WITH CASTRATION RESISTANT PROSTATE CANCER BY USE OF NATION-WIDE POPULATION-BASED OBSERVATIONAL DATA
Ventimiglia E; Bill-Axelson A; Aly M; Eklund M; Stattin P; Garmo H
Journal article: INVESTIGATIVE UROLOGY. 2022;207(Supplement 5):e41
PD03-02 LONG-TERM EFFECTS OF 5Α-REDUCTASE INHIBITORS ON PROSTATE CANCER MORTALITY - A LARGE POPULATION-BASED PROSPECTIVE STUDY
Björnebo L; Nordström T; Discacciati A; Palsdottir T; Aly M; Grönberg H; Eklund M; Lantz A
Article: BJUI COMPASS. 2022;3(2):173-183
Mortality in men with castration-resistant prostate cancer-A long-term follow-up of a population-based real-world cohort
Khoshkar Y; Westerberg M; Adolfsson J; Bill-Axelson A; Olsson H; Eklund M; Akre O; Garmo H; Aly M
Article: BJU INTERNATIONAL. 2022;129(3):318-324
The 90-day cause-specific mortality after radical prostatectomy: a nationwide population-based study
Bjorklund J; Stattin P; Ronmark E; Aly M; Akre O
Journal article: EUROPEAN UROLOGY. 2022;81:s792-s793
A0527 Disease trajectories and outcomes for men with castration resistant prostate cancer by use of nation-wide population-based observational data
Ventimiglia E; Bill-Axelson A; Aly M; Eklund M; Stattin P; Garmo H
Journal article: EUROPEAN UROLOGY. 2022;81:s561-s562
A0362 Long-term effects of 5α-reductase inhibitors on prostate cancer mortality: A large population-based prospective study
Björnebo L; Nordström T; Discacciati A; Palsdottir T; Aly M; Grönberg H; Eklund M; Lantz A
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2021;385(10):908-920
MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
Eklund M; Jaderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Groenberg H; Nordstroem T
Article: LANCET ONCOLOGY. 2021;22(9):1240-1249
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial
Nordstrom T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jaderling F; Eklund M; Gronberg H
Article: EUROPEAN UROLOGY ONCOLOGY. 2021;4(4):570-579
Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study
Karlsson Q; Brook MN; Dadaev T; Wakerell S; Saunders EJ; Muir K; Neal DE; Giles GG; MacInnis RJ; Thibodeau SN; McDonnell SK; Cannon-Albright L; Teixeira MR; Paulo P; Cardoso M; Huff C; Li D; Yao Y; Scheet P; Permuth JB; Stanford JL; Dai JY; Ostrander EA; Cussenot O; Cancel-Tassin G; Hoegel J; Herkommer K; Schleutker J; Tammela TLJ; Rathinakannan V; Sipeky C; Wiklund F; Gronberg H; Aly M; Isaacs WB; Dickinson JL; FitzGerald LM; Chua MLK; Nguyen-Dumont T; Consortium P; Schaid DJ; Southey MC; Eeles RA; Kote-Jarai Z
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2021;55(4):299-306
Real world treatment utilization patterns in patients with castration-resistant prostate cancer
Vigneswaran HT; Warnqvist A; Andersson TML; Leval A; Eklund M; Nordstrom T; Eloranta S; Schain F; Dearden L; Liwing J; Mehra M; Nair S; Pettersson A; Akre O; Aly M
Journal article: EUROPEAN UROLOGY. 2021;79:s1429
P1014 Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, magnetic resonance imaging and targeted prostate biopsies: The STHLM3MRI trial
Nordström T; Discacciati A; Bergman M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H
Journal article: EUROPEAN UROLOGY. 2021;79:s1430
P1015 MRI-targeted or systematic biopsies in prostate cancer screening: The STHLM3MRI trial
Eklund M; Jäderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Grönberg H; Nordström T
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2021;24:11-16
Identifying Prostate Cancer Among Men with Lower Urinary Tract Symptoms
Nordstrom T; Engel JC; Bergman M; Egevad L; Aly M; Eklund M; Palsdottir T; Gronberg H
Article: JOURNAL OF ROBOTIC SURGERY. 2021;15(1):105-114
Oncologic outcomes of patients with incidental prostate cancer who underwent RARC: a comparison between nerve sparing and non-nerve sparing approach
Chessa F; Moller A; Collins J; Laurin O; Aly M; Schiavina R; Adding C; Distefano C; Akre O; Bertaccini A; Hosseini A; Brunocilla E; Wiklund P
Article: NATURE GENETICS. 2021;53(1):65-75
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
Conti DV; Darst BF; Moss LC; Saunders EJ; Sheng X; Chou A; Schumacher FR; Al Olama AA; Benlloch S; Dadaev T; Brook MN; Sahimi A; Hoffmann TJ; Takahashi A; Matsuda K; Momozawa Y; Fujita M; Muir K; Lophatananon A; Wan P; Le Marchand L; Wilkens LR; Stevens VL; Gapstur SM; Carter BD; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Giles GG; Southey MC; MacInnis RJ; Cybulski C; Wokolorczyk D; Lubinski J; Neal DE; Donovan JL; Hamdy FC; Martin RM; Nordestgaard BG; Nielsen SF; Weischer M; Bojesen SE; Roder MA; Iversen P; Batra J; Chambers S; Moya L; Horvath L; Clements JA; Tilley W; Risbridger GP; Gronberg H; Aly M; Szulkin R; Eklund M; Nordstrom T; Pashayan N; Dunning AM; Ghoussaini M; Travis RC; Key TJ; Riboli E; Park JY; Sellers TA; Lin H-Y; Albanes D; Weinstein SJ; Mucci LA; Giovannucci E; Lindstrom S; Kraft P; Hunter DJ; Penney KL; Turman C; Tangen CM; Goodman PJ; Thompson IMJ; Hamilton RJ; Fleshner NE; Finelli A; Parent M-E; Stanford JL; Ostrander EA; Geybels MS; Koutros S; Freeman LEB; Stampfer M; Wolk A; Hakansson N; Andriole GL; Hoover RN; Machiela MJ; Sorensen KD; Borre M; Blot WJ; Zheng W; Yeboah ED; Mensah JE; Lu Y-J; Zhang H-W; Feng N; Mao X; Wu Y; Zhao S-C; Sun Z; Thibodeau SN; McDonnell SK; Schaid DJ; West CML; Burnet N; Barnett G; Maier C; Schnoeller T; Luedeke M; Kibel AS; Drake BF; Cussenot O; Cancel-Tassin G; Menegaux F; Truong T; Koudou YA; John EM; Grindedal EM; Maehle L; Khaw K-T; Ingles SA; Stern MC; Vega A; Gomez-Caamano A; Fachal L; Rosenstein BS; Kerns SL; Ostrer H; Teixeira MR; Paulo P; Brandao A; Watya S; Lubwama A; Bensen JT; Fontham ETH; Mohler J; Taylor JA; Kogevinas M; Llorca J; Castano-Vinyals G; Cannon-Albright L; Teerlink CC; Huff CD; Strom SS; Multigner L; Blanchet P; Brureau L; Kaneva R; Slavov C; Mitev V; Leach RJ; Weaver B; Brenner H; Cuk K; Holleczek B; Saum K-U; Klein EA; Hsing AW; Kittles RA; Murphy AB; Logothetis CJ; Kim J; Neuhausen SL; Steele L; Ding YC; Isaacs WB; Nemesure B; Hennis AJM; Carpten J; Pandha H; Michael A; De Ruyck K; De Meerleer G; Ost P; Xu J; Razack A; Lim J; Teo S-H; Newcomb LF; Lin DW; Fowke JH; Neslund-Dudas C; Rybicki BA; Gamulin M; Lessel D; Kulis T; Usmani N; Singhal S; Parliament M; Claessens F; Joniau S; Van den Broeck T; Gago-Dominguez M; Castelao JE; Martinez ME; Larkin S; Townsend PA; Aukim-Hastie C; Bush WS; Aldrich MC; Crawford DC; Srivastava S; Cullen JC; Petrovics G; Casey G; Roobol MJ; Jenster G; van Schaik RHN; Hu JJ; Sanderson M; Varma R; McKean-Cowdin R; Torres M; Mancuso N; Berndt SI; Van den Eeden SK; Easton DF; Chanock SJ; Cook MB; Wiklund F; Nakagawa H; Witte JS; Eeles RA; Kote-Jarai Z; Haiman CA
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2020;28(10):1467-1475
The effect of sample size on polygenic hazard models for prostate cancer
Karunamuni RA; Huynh-Le M-P; Fan CC; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; Gronberg H; Wiklund F; Aly M; Schleutker J; Sipeky C; Tammela TLJ; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Ben S; Holleczek B; Park JY; Sellers TA; Lin H-Y; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Mills IG; Andreassen OA; Dale AM; Seibert TM
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2020;29(9):1731-1738
A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data
Huynh-Le M-P; Fan CC; Karunamuni R; Walsh EI; Turner EL; Lane JA; Martin RM; Neal DE; Donovan JL; Hamdy FC; Parsons JK; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; Gronberg H; Wiklund F; Aly M; Schleutker J; Sipeky C; Tammela TLJ; Nordestgaard BG; Key TJ; Travis RC; Pharoah PD; Pashayan N; Khaw K-T; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright LA; Brenner H; Ben S; Holleczek B; Park JY; Sellers TA; Lin H-Y; Slavov CK; Kaneva RP; Mitev VI; Batra J; Clements JA; Spurdle AB; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Mills IG; Andreassen OA; Dale AM; Seibert TM
Article: BMC CANCER. 2020;20(1):805
The CanMoRe trial - evaluating the effects of an exercise intervention after robotic-assisted radical cystectomy for urinary bladder cancer: the study protocol of a randomised controlled trial
Porserud A; Karlsson P; Rydwik E; Aly M; Henningsohn L; Nygren-Bonnier M; Hagstromer M
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2020;19:e1522-e1524
1017 Oncologic outcomes of robot assisted vs. open radical cystectomy: Results from a high-volume referral center
Chessa F; Luciani L; Moller A; Laurin O; Aly M; Adding C; Schiavina R; Hosseini A; Brunocilla E; Akre O; Wiklund P
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2020;19:e182
58 Adding random systematic biopsies to MRI-fusion targeted prostate biopsy procedures: Always, in selected cases, or never?
Bergman MCA; Mortezawi A; Picker W; Aly M; Jäderling F; Haug E; Eklund M; Nordström T
Journal article: INVESTIGATIVE UROLOGY. 2020;203(Supplement 4)
PD10-06 REAL-WORLD TREATMENT PATTERNS IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER
Vigneswaran* HT; Warnqvist A; Andersson TML; Leval A; Schain F; Liwing J; Eloranta S; Pettersson A; Akre O; Aly M
Journal article: INVESTIGATIVE UROLOGY. 2020;203(Supplement 4)
MP74-06 90-DAY CAUSE-SPECIFIC MORTALITY AFTER RADICAL PROSTATECTOMY. NATIONWIDE POPULATION-BASED SWEDISH REGISTRY STUDY
Björklund* J; Stattin P; Aly M; Akre O
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2020;54(2):115-121
Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden
Aly M; Leval A; Schain F; Liwing J; Lawson J; Vago E; Nordstrom T; Andersson TM-L; Sjoland E; Wang C; Eloranta S; Akre O
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6_suppl):tps378
MRI-targeted biopsies in prostate cancer screening and the value of its combination with blood-based risk-prediction: The randomized, diagnostic study STHLM3MRI.
Nordström T; Discacciati A; Jäderling F; Karlsson SG; Aly M; Gronberg H; Eklund M
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2020;54(1):1-6
Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml
Engel JC; Palsdottir T; Aly M; Egevad L; Gronberg H; Eklund M; Nordstrom T
Article: JAMA NETWORK OPEN. 2019;2(11):e1914689
Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results
Beckmann K; Crawley D; Nordstrom T; Aly M; Olsson H; Lantz A; Abd Jalal NB; Garmo H; Adolfsson J; Eklund M; Van Hemelrijck M
Article: EJSO. 2019;45(10):1847-1853
Objectively measured mobilisation is enhanced by a new behaviour support tool in patients undergoing abdominal cancer surgery
Porserud A; Aly M; Nygren-Bonnier M; Hagstromer M
Article: EUROPEAN UROLOGY ONCOLOGY. 2019;2(5):490-496
A Unified Prostate Cancer Risk Prediction Model Combining the Stockholm3 Test and Magnetic Resonance Imaging
Palsdottir T; Nordstrom T; Aly M; Jaderling F; Clements M; Gronberg H; Eklund M
Article: EUROPEAN UROLOGY FOCUS. 2019;5(5):842-848
Poor Follow-up After Elevated Prostate-specific Antigen Tests: A Population-based Cohort Study
Aly M; Clements M; Weibull CE; Nordstrom T; Naslund E; Adolfsson J; Gronberg H
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2019;22(3):391-398
Preoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery
Jaderling F; Akre O; Aly M; Bjorklund J; Olsson M; Adding C; Oberg M; Blomqvist L; Nyberg T; Wiklund P; Carlsson S
Article: BMC UROLOGY. 2019;19(1):73
Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?
Beckmann K; Kinsella N; Olsson H; Lantz AW; Nordstrom T; Aly M; Adolfsson J; Eklund M; Van Hemelrijck M
Article: BMJ OPEN. 2019;9(6):e027816
Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
Nordstrom T; Jaderling F; Carlsson S; Aly M; Gronberg H; Eklund M
Journal article: JOURNAL OF RADIATION ONCOLOGY. 2019;8(2):225-231
Salvage radiation therapy following radical prostatectomy in Stockholm County in 2008-2016
Falk J; Aly M; Berglund A; Nordstrom T; Valdman A
Journal article: INVESTIGATIVE UROLOGY. 2019;201(Supplement 4)
MP48-18 IS PSA ‘SCREENING’ BEHAVIOUR ASSOCIATED WITH UPTAKE OF ACTIVE SURVEILLANCE IN MEN WITH LOW RISK PROSTATE CANCER?
Beckmann* K; Kinsella N; Olsen H; Wallerstedt-Lantz A; Nordstrom T; Aly M; Adolfsson J; Eklund M; Van Hemelrijck M
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2019;18(1):e1349-e1350
1006 Evaluation of enhanced mobilisation with individual goal-setting and self-monitoring after abdominal surgery due to cancer
Porserud A; Aly M; Nygren-Bonnier M; Hagströmer M
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2019;18(1):e287-e289
218 Oncologic outcomes of patients with incidental prostate cancer who underwent robot-assisted radical cystectomy: A comparison between nerve sparing and non-nerve sparing approach
Chessa F; Moller A; Laurin O; Adding C; Aly M; Collins J; Luciani L; Schiavina R; Brunocilla E; Akre O; Hosseini A; Wiklund P
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2019;22(1):137-142
The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort
Moller A; Olsson H; Gronberg H; Eklund M; Aly M; Nordstrom T
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2019;18(1):e1532
1132 The effect of common diabetes medications on PSA levels in men without prostate cancer
Jalal NBA; Garmo H; Nordstrom T; Aly M; Eklund M; Aldofsson J; Van Hemelrijck M; Beckmann K
Article: PLOS ONE. 2019;14(6):e0218280
Are Prostate Specific-Antigen (PSA) and age associated with the risk of ISUP Grade 1 prostate cancer? Results from 72 996 individual biopsy cores in 6 083 men from the Stockholm3 study
Palsdottir T; Nordstrom T; Aly M; Lindberg J; Clements M; Egevad L; Gronberg H; Eklund M
Article: EUROPEAN UROLOGY. 2018;74(6):722-728
Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging
Gronberg H; Eklund M; Picker W; Aly M; Jaderling F; Adolfsson J; Landquist M; Haug ES; Strom P; Carlsson S; Nordstrom T
Article: GENOME MEDICINE. 2018;10(1):85
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis
Mayrhofer M; De Laere B; Whitington T; Van Oyen P; Ghysel C; Ampe J; Ost P; Demey W; Hoekx L; Schrijvers D; Brouwers B; Lybaert W; Everaert E; De Maeseneer D; Strijbos M; Bols A; Fransis K; Oeyen S; van Dam P-J; Van den Eynden G; Rutten A; Aly M; Nordstrom T; Van Laere S; Rantalainen M; Rajan P; Egevad L; Ullen A; Yachnin J; Dirix L; Gronberg H; Lindberg J
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2018;17(14):e2898-e2899
P078 Lower Urinary Tract Symptoms (LUTS) not associated to increased risk of prostate cancer
Engel JC; Aly M; Grönberg H; Eklund M; Nordström T
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2018;17(8):225-226
P95 Oncologic outcomes of robot assisted vs open radical cystectomy: Results from a high-volume referral centre
Chessa F; Möller A; Schiavina R; Borghesi M; Laurin O; Dababneh H; Aly M; Adding C; Miyakawa A; Pultrone C; Akre O; Hosseini A; Brunocilla E; Wiklund P
Article: EUROPEAN UROLOGY FOCUS. 2018;4(5):707-710
The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer Testing
Eklund M; Nordstrom T; Aly M; Adolfsson J; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Presti JC; StLezin M; Clements M; Egevad L; Gronberg H
Article: EUROPEAN UROLOGY. 2018;74(2):204-210
The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential
Strom P; Nordstrom T; Aly M; Egevad L; Gronberg H; Eklund M
Article: NATURE GENETICS. 2018;50(7):928-936
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Schumacher FR; Al Olama AA; Berndt SI; Benlloch S; Ahmed M; Saunders EJ; Dadaev T; Leongamornlert D; Anokian E; Cieza-Borrella C; Goh C; Brook MN; Sheng X; Fachal L; Dennis J; Tyrer J; Muir K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman PJ; Thompson IMJ; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger GP; Gronberg H; Aly M; Nordstrom T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Hakansson N; West CML; Dunning AM; Burnet N; Mucci LA; Giovannucci E; Andriole GL; Cussenot O; Cancel-Tassin G; Koutros S; Freeman LEB; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein BS; Kerns SL; Ostrer H; Lu Y-J; Zhang H-W; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gomez-Caamano A; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castano-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin H-Y; Stanford JL; Cybulski C; Wokolorczyk D; Lubinski J; Ostrander EA; Geybels MS; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Roder MA; Iversen P; Brenner H; Cuk K; Holleczek B; Maier C; Luedeke M; Schnoeller T; Kim J; Logothetis CJ; John EM; Teixeira MR; Paulo P; Cardoso M; Neuhausen SL; Steele L; Ding YC; De Ruyck K; De Meerleer G; Ost P; Razack A; Lim J; Teo S-H; Lin DW; Newcomb LF; Lessel D; Gamulin M; Kulis T; Kaneva R; Usmani N; Singhal S; Slavov C; Mitev V; Parliament M; Claessens F; Joniau S; Van den Broeck T; Larkin S; Townsend PA; Aukim-Hastie C; Dominguez MG; Castelao JE; Martinez ME; Roobol MJ; Jenster G; van Schaik RHN; Menegaux F; Truong T; Koudou YA; Xu J; Khaw K-T; Cannon-Albright L; Pandha H; Michael A; Thibodeau SN; McDonnell SK; Schaid DJ; Lindstrom S; Turman C; Ma J; Hunter DJ; Riboli E; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Cui Z; Kraft P; Conti DV; Easton DF; Wiklund F; Chanock SJ; Henderson BE; Kote-Jarai Z; Haiman CA; Eeles RA
Article: NATURE COMMUNICATIONS. 2018;9(1):2256
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
Dadaev T; Saunders EJ; Newcombe PJ; Anokian E; Leongamornlert DA; Brook MN; Cieza-Borrella C; Mijuskovic M; Wakerell S; Al Olama AA; Schumacher FR; Berndt SI; Benlloch S; Ahmed M; Goh C; Sheng X; Zhang Z; Muir K; Govindasami K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman P; Thompson IMJ; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger G; Gronberg H; Aly M; Nordstrom T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Hakansson N; West C; Dunning AM; Burnet N; Mucci L; Giovannucci E; Andriole G; Cussenot O; Cancel-Tassin G; Koutros S; Freeman LEB; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein B; Kerns S; Ostrer H; Lu Y-J; Zhang H-W; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gomez-Caamano A; Fachal L; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castano-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin H-Y; Stanford JL; Cybulski C; Wokolorczyk D; Lubinski J; Ostrander EA; Geybels MS; Nordestgaard BG; Nielsen SF; Weisher M; Bisbjerg R; Roder MA; Iversen P; Brenner H; Cuk K; Holleczek B; Maier C; Luedeke M; Schnoeller T; Kim J; Logothetis CJ; John EM; Teixeira MR; Paulo P; Cardoso M; Neuhausen SL; Steele L; Ding YC; De Ruyck K; De Meerleer G; Ost P; Razack A; Lim J; Teo S-H; Lin DW; Newcomb LF; Lessel D; Gamulin M; Kulis T; Kaneva R; Usmani N; Slavov C; Mitev V; Parliament M; Singhal S; Claessens F; Joniau S; Van den Broeck T; Larkin S; Townsend PA; Aukim-Hastie C; Gago-Dominguez M; Castelao JE; Martinez ME; Roobol MJ; Jenster G; van Schaik RHN; Menegaux F; Truong T; Koudou YA; Xu J; Khaw K-T; Cannon-Albright L; Pandha H; Michael A; Kierzek A; Thibodeau SN; McDonnell SK; Schaid DJ; Lindstrom S; Turman C; Ma J; Hunter DJ; Riboli E; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Kraft P; Freedman M; Wiklund F; Chanock S; Henderson BE; Easton DF; Haiman CA; Eeles RA; Conti DV; Kote-Jarai Z
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2018;21(1):57-63
Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer
Nordstrom T; Akre O; Aly M; Gronberg H; Eklund M
Article: EUROPEAN UROLOGY FOCUS. 2018;4(3):385-387
Balancing Overdiagnosis and Early Detection of Prostate Cancer using the Stockholm-3 Model
Nordstrom T; Gronberg H; Adolfsson J; Egevad L; Aly M; Eklund M
Article: BMJ-BRITISH MEDICAL JOURNAL. 2018;360:j5757
Polygenic hazard score to guide screening for aggressive - prostate cancer: development and validation in large scale - cohorts
Seibert TM; Fan CC; Wang Y; Zuber V; Karunamuni R; Parsons JK; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; Gronberg H; Wiklund F; Aly M; Schleutker J; Sipeky C; Tammela TLJ; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Roder MA; Iversen P; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Cuk K; Saum K-U; Park JY; Sellers TA; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Karow DS; Mills IG; Andreassen OA; Dale AM
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2017;16(10):e2628-e2629
O2 A multistep approach for detection of prostate cancer using prostate-specific antigen, the Stockholm 3 Test, and MRI-targeted Biopsies: Initial data from the STHLM3 MRI Project
Nordström; Picker W; Aly M; Jäderling F; Adolfsson J; Ström P; Haug ES; Eklund M; Carlsson S; Grönberg H
Article: BRITISH JOURNAL OF CANCER. 2017;117(5):734-743
Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium
Lophatananon A; Stewart-Brown S; Kote-Jarai Z; Al Olama AA; Garcia SB; Neal DE; Hamdy FC; Donovan JL; Giles GG; Fitzgerald LM; Southey MC; Pharoah P; Pashayan N; Gronberg H; Wiklund F; Aly M; Stanford JL; Brenner H; Dieffenbach AK; Arndt V; Park JY; Lin H-Y; Sellers T; Slavov C; Kaneva R; Mitev V; Batra J; Spurdle A; Clements JA; Easton D; Eeles RA; Muir K
Article: CANCER DISCOVERY. 2016;6(9):1052-1067
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
Kar SP; Beesley J; Al Olama AA; Michailidou K; Tyrer J; Kote-Jarai ZA; Lawrenson K; Lindstrom S; Ramus SJ; Thompson DJ; Kibel AS; Dansonka-Mieszkowska A; Michael A; Dieffenbach AK; Gentry-Maharaj A; Whittemore AS; Wolk A; Monteiro A; Peixoto A; Kierzek A; Cox A; Rudolph A; Gonzalez-Neira A; Wu AH; Lindblom A; Swerdlow A; Ziogas A; Ekici AB; Burwinkel B; Karlan BY; Nordestgaard BG; Blomqvist C; Phelan C; McLean C; Pearce CL; Vachon C; Cybulski C; Slavov C; Stegmaier C; Maier C; Ambrosone CB; Hogdall CK; Teerlink CC; Kang D; Tessier DC; Schaid DJ; Stram DO; Cramer DW; Neal DE; Eccles D; Flesch-Janys D; Edwards DRV; Wokozorczyk D; Levine DA; Yannoukakos D; Sawyer EJ; Bandera EV; Poole EM; Goode EL; Khusnutdinova E; Hogdall E; Song F; Bruinsma F; Heitz F; Modugno F; Hamdy FC; Wiklund F; Giles GG; Olsson H; Wildiers H; Ulmer H-U; Pandha H; Risch HA; Darabi H; Salvesen HB; Nevanlinna H; Gronberg H; Brenner H; Brauch H; Anton-Culver H; Song H; Lim H-Y; McNeish I; Campbell I; Vergote I; Gronwald J; Lubinski J; Stanford JL; Bentez J; Doherty JA; Permuth JB; Chang-Claude J; Donovan JL; Dennis J; Schildkraut JM; Schleutker J; Hopper JL; Kupryjanczyk J; Park JY; Figueroa J; Clements JA; Knight JA; Peto J; Cunningham JM; Pow-Sang J; Batra J; Czene K; Lu KH; Herkommer K; Khaw K-T; Matsuo K; Muir K; Offitt K; Chen K; Moysich KB; Aittomaki K; Odunsi K; Kiemeney LA; Massuger LFAG; Fitzgerald LM; Cook LS; Cannon-Albright L; Hooning MJ; Pike MC; Bolla MK; Luedeke M; Teixeira MR; Goodman MT; Schmidt MK; Riggan M; Aly M; Rossing MA; Beckmann MW; Moisse M; Sanderson M; Southey MC; Jones M; Lush M; Hildebrandt MAT; Hou M-F; Schoemaker MJ; Garcia-Closas M; Bogdanova N; Rahman N; Le ND; Orr N; Wentzensen N; Pashayan N; Peterlongo P; Guenel P; Brennan P; Paulo P; Webb PM; Broberg P; Fasching PA; Devilee P; Wang Q; Cai Q; Li Q; Kaneva R; Butzow R; Kopperud RK; Schmutzler RK; Stephenson RA; MacInnis RJ; Hoover RN; Winqvist R; Ness R; Milne RL; Travis RC; Benlloch S; Olson SH; McDonnell SK; Tworoger SS; Maia SA; Berndt S; Lee SC; Teo S-H; Thibodeau SN; Bojesen SE; Gapstur SM; Kjaer SK; Pejovic T; Tammela TLJ; Doerk T; Bruening T; Wahlfors T; Key TJ; Edwards TL; Menon U; Hamann U; Mitev V; Kosma V-M; Setiawan VW; Kristensen V; Arndt V; Vogel W; Zheng W; Sieh W; Blot WJ; Kluzniak W; Shu X-O; Gao Y-T; Schumacher F; Freedman ML; Berchuck A; Dunning AM; Simard J; Haiman CA; Spurdle A; Sellers TA; Hunter DJ; Henderson BE; Kraft P; Chanock SJ; Couch FJ; Hall P; Gayther SA; Easton DF; Chenevix-Trench G; Eeles R; Pharoah PDP; Lambrechts D
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(15):5050
The Stockholm-3 (STHLM3) model to improve prostate cancer testing in men 50-69 years compared to current clinical practice.
Gronberg H; Adolfsson J; Aly M; Nordstrom T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Article: NATURE COMMUNICATIONS. 2016;7:10979
Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation
Gusev A; Shi H; Kichaev G; Pomerantz M; Li F; Long HW; Ingles SA; Kittles RA; Strom SS; Rybicki BA; Nemesure B; Isaacs WB; Zheng W; Pettaway CA; Yeboah ED; Tettey Y; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Chokkalingam AP; John EM; Murphy AB; Signorello LB; Carpten J; Leske MC; Wu S-Y; Hennis AJM; Neslund-Dudas C; Hsing AW; Chu L; Goodman PJ; Klein EA; Witte JS; Casey G; Kaggwa S; Cook MB; Stram DO; Blot WJ; Eeles RA; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Southey MC; Fitzgerald LM; Gronberg H; Wiklund F; Aly M; Henderson BE; Schleutker J; Wahlfors T; Tammela TLJ; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Stanford JL; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Teerlink C; Brenner H; Dieffenbach AK; Arndt V; Park JY; Sellers TA; Lin H-Y; Slavov C; Kaneva R; Mitev V; Batra J; Spurdle A; Clements JA; Teixeira MR; Pandha H; Michael A; Paulo P; Maia S; Kierzek A; Conti DV; Albanes D; Berg C; Berndt SI; Campa D; Crawford ED; Diver WR; Gapstur SM; Gaziano JM; Giovannucci E; Hoover R; Hunter DJ; Johansson M; Kraft P; Le Marchand L; Lindstrom S; Navarro C; Overvad K; Riboli E; Siddiq A; Stevens VL; Trichopoulos D; Vineis P; Yeager M; Trynka G; Raychaudhuri S; Schumacher FR; Price AL; Freedman ML; Haiman CA; Pasaniuc B; Cook M; Guy M; Govindasami K; Leongamornlert D; Sawyer EJ; Wilkinson R; Saunders EJ; Tymrakiewicz M; Dadaev T; Morgan A; Fisher C; Hazel S; Livni N; Lophatananon A; Pedersen J; Hopper JL; Adolfson J; Stattin P; Johansson J-E; Cavalli-Bjoerkman C; Karlsson A; Broms M; Auvinen A; Kujala P; Maeaettaenen L; Murtola T; Taari K; Weischer M; Nielsen SF; Klarskov P; Roder A; Iversen P; Wallinder H; Gustafsson S; Cox A; Brown P; George A; Marsden G; Lane A; Davis M; Zheng W; Signorello LB; Blot WJ; Tillmans L; Riska S; Wang L; Rinckleb A; Lubiski J; Stegmaier C; Pow-Sang J; Park H; Radlein S; Rincon M; Haley J; Zachariah B; Kachakova D; Popov E; Mitkova A; Vlahova A; Dikov T; Christova S; Heathcote P; Wood G; Malone G; Saunders P; Eckert A; Yeadon T; Kerr K; Collins A; Turner M; Srinivasan S; Kedda M-A; Alexander K; Omara T; Wu H; Henrique R; Pinto P; Santos J; Barros-Silva J
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2016;50(2):104-109
A population-based study on the association between educational length, prostate-specific antigen testing and use of prostate biopsies
Nordstrom T; Bratt O; Ortegren J; Aly M; Adolfsson J; Gronberg H
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2016;15(3):e86
86 The STHLM3 model improves prostate cancer testing in men 50-69 years - further health economic and clinic evaluation
Grönberg H; Adolfsson J; Aly M; Nordström T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Article: LANCET ONCOLOGY. 2015;16(16):1667-1676
Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study
Gronberg H; Adolfsson J; Aly M; Nordstrom T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2015;24(11):1796-1800
Genome-Wide Association Study of Prostate Cancer-Specific Survival
Szulkin R; Karlsson R; Whitington T; Aly M; Gronberg H; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Southey MC; FitzGerald LM; Henderson BE; Schumacher FR; Haiman CA; Sipeky C; Tammela TLJ; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah PDP; Pashayan N; Khaw K-T; Stanford JL; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Lubinski J; Kluzniak W; Cannon-Albright L; Brenner H; Herrmann V; Holleczek B; Park JY; Sellers TA; Lim H-Y; Slavov C; Kaneva RP; Mitev VI; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Batra J; Clements JA; Albanes D; Andriole GL; Berndt SI; Chanock S; Gapstur SM; Giovannucci EL; Hunter DJ; Kraft P; Le Marchand L; Ma J; Mondul AM; Penney KL; Stampfer MJ; Stevens VL; Weinstein SJ; Trichopoulou A; Bueno-de-Mesquita BH; Tjonneland A; Cox DG; Maehle L; Schleutker J; Lindstroem S; Wiklund F
Article: HUMAN MOLECULAR GENETICS. 2015;24(19):5589-5602
Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans
Al Olama AA; Dadaev T; Hazelett DJ; Li Q; Leongamornlert D; Saunders EJ; Stephens S; Cieza-Borrella C; Whitmore I; Garcia SB; Giles GG; Southey MC; Fitzgerald L; Gronberg H; Wiklund F; Aly M; Henderson BE; Schumacher F; Haiman CA; Schleutker J; Wahlfors T; Tammela TL; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Stanford JL; Thibodeau SN; Mcdonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Butterbach K; Arndt V; Park JY; Sellers T; Lin H-Y; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Govindasami K; Guy M; Lophatonanon A; Muir K; Vinuela A; Brown AA; Freedman M; Conti DV; Easton D; Coetzee GA; Eeles RA; Kote-Jarai Z
Article: PROSTATE. 2015;75(13):1467-1474
Prediction of Individual Genetic Risk to Prostate Cancer Using a Polygenic Score
Szulkin R; Whitington T; Eklund M; Aly M; Eeles RA; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Southey MC; Fitzgerald LM; Henderson BE; Schumacher F; Haiman CA; Schleutker J; Wahlfors T; Tammela TLJ; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Stanford JL; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Lubinski J; Kluzniak W; Cannon-Albright L; Brenner H; Butterbach K; Stegmaier C; Park JY; Sellers T; Lim H-Y; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Gronberg H; Wiklund F
Article: PROSTATE. 2015;75(9):947-956
Rapid Increase in Multidrug-Resistant Enteric Bacilli Blood Stream Infection After Prostate Biopsy-A 10-Year Population-Based Cohort Study
Aly M; Dyrdak R; Nordstrom T; Jalal S; Weibull CE; Giske CG; Gronberg H
Article: NATURE GENETICS. 2014;46(10):1103-1109
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
Al Olama AA; Kote-Jarai Z; Berndt SI; Conti DV; Schumacher F; Han Y; Benlloch S; Hazelett DJ; Wang Z; Saunders E; Leongamornlert D; Lindstrom S; Jugurnauth-Little S; Dadaev T; Tymrakiewicz M; Stram DO; Rand K; Wan P; Stram A; Sheng X; Pooler LC; Park K; Xia L; Tyrer J; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Yeager M; Burdette L; Chung CC; Hutchinson A; Yu K; Goh C; Ahmed M; Govindasami K; Guy M; Tammela TLJ; Auvinen A; Wahlfors T; Schleutker J; Visakorpi T; Leinonen KA; Xu J; Aly M; Donovan J; Travis RC; Key TJ; Siddiq A; Canzian F; Khaw K-T; Takahashi A; Kubo M; Pharoah P; Pashayan N; Weischer M; Nordestgaard BG; Nielsen SF; Klarskov P; Roder MA; Iversen P; Thibodeau SN; McDonnell SK; Schaid DJ; Stanford JL; Kolb S; Holt S; Knudsen B; Coll AH; Gapstur SM; Diver WR; Stevens VL; Maier C; Luedeke M; Herkommer K; Rinckleb AE; Strom SS; Pettaway C; Yeboah ED; Tettey Y; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Choklcalingam AP; Cannon-Albright L; Cybulski C; Wokolorczyk D; Kluzniak W; Park J; Sellers T; Lin H-Y; Isaacs WB; Partin AW; Brenner H; Dieffenbach AK; Stegmaier C; Chen C; Giovannucci EL; Ma J; Stampfer M; Penney KL; Mucci L; John EM; Ingles SA; Kittles RA; Murphy AB; Pandha H; Michael A; Kierzek AM; Blot W; Signorello LB; Zheng W; Albanes D; Virtamo J; Weinstein S; Nemesure B; Carpten J; Leske C; Wu S-Y; Hennis A; Kibel AS; Rybicki BA; Neslund-Dudas C; Hsing AW; Chu L; Goodman PJ; Klein EA; Zheng SL; Batra J; Clements J; Spurdle A; Teixeira MR; Paulo P; Maia S; Slavov C; Kaneva R; Mitev V; Witte JS; Casey G; Gillanders EM; Seminara D; Riboli E; Hamdy FC; Coetzee GA; Li Q; Freedman ML; Hunter DJ; Muir K; Gronberg H; Nea DE; Southey M; Giles GG; Severi G; Cook MB; Nakagawa H; Wiklund F; Kraft P; Chanock SJ; Henderson BE; Easton DF; Eeles RA; Haiman CA
Article: EUROPEAN UROLOGY. 2014;65(6):1184-1190
A Genetic Score Can Identify Men at High Risk for Prostate Cancer Among Men With Prostate-Specific Antigen of 1-3 ng/ml
Nordstrom T; Aly M; Eklund M; Egevad L; Gronberg H
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2014;13(1):e860
860 STHLM3 – a prospective diagnostic study of prostate cancer
Gronberg H; Eklund M; Clements M; Nordström T; Aly M; Egevad L; Wiklund F; Brandeberg Y; Wiklund P; Adolfsson J
Article: PLOS GENETICS. 2014;10(2):e1004129
Fine-Mapping the HOXB Region Detects Common Variants Tagging a Rare Coding Allele: Evidence for Synthetic Association in Prostate Cancer
Saunders EJ; Dadaev T; Leongamornlert DA; Jugurnauth-Little S; Tymrakiewicz M; Wiklund F; Al Olama AA; Benlloch S; Neal DE; Hamdy FC; Donovan JL; Giles GG; Severi G; Gronberg H; Aly M; Haiman CA; Schumacher F; Henderson BE; Lindstrom S; Kraft P; Hunter DJ; Gapstur S; Chanock S; Berndt SI; Albanes D; Andriole G; Schleutker J; Weischer M; Nordestgaard BG; Canzian F; Campa D; Riboli E; Key TJ; Travis RC; Ingles SA; John EM; Hayes RB; Pharoah P; Khaw K-T; Stanford JL; Ostrander EA; Signorello LB; Thibodeau SN; Schaid D; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park JY; Kaneva R; Batra J; Clements JA; Teixeira MR; Xu J; Mikropoulos C; Goh C; Govindasami K; Guy M; Wilkinson RA; Sawyer EJ; Morgan A; Easton DF; Muir K; Eeles RA; Kote-Jarai Z
Article: EUROPEAN UROLOGY. 2014;65(1):169-176
A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk
Karlsson R; Aly M; Clements M; Zheng L; Adolfsson J; Xu J; Gronberg H; Wiklund F
Article: NATURE GENETICS. 2013;45(4):385-391e2
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Eeles RA; Al Olama AA; Benlloch S; Saunders EJ; Leongamornlert DA; Tymrakiewicz M; Ghoussaini M; Luccarini C; Dennis J; Jugurnauth-Little S; Dadaev T; Neal DE; Hamdy FC; Donovan JL; Muir K; Giles GG; Severi G; Wiklund F; Gronberg H; Haiman CA; Schumacher F; Henderson BE; Le Marchand L; Lindstrom S; Kraft P; Hunter DJ; Gapstur S; Chanock SJ; Berndt SI; Albanes D; Andriole G; Schleutker J; Weischer M; Canzian F; Riboli E; Key TJ; Travis RC; Campa D; Ingles SA; John EM; Hayes RB; Pharoah PDP; Pashayan N; Khaw K-T; Stanford JL; Ostrander EA; Signorello LB; Thibodeau SN; Schaid D; Maier C; Vogel W; Kibel AS; Cybulski C; Lubhiski J; Cannon-Albright L; Brenner H; Park JY; Kaneva R; Batra J; Spurdle AB; Clements JA; Teixeira MR; Dicks E; Lee A; Dunning AM; Baynes C; Conroy D; Maranian MJ; Ahmed S; Govindasami K; Guy M; Wilkinson RA; Sawyer EJ; Morgan A; Dearnaley DP; Horwich A; Huddart RA; Khoo VS; Parker CC; Van As NJ; Woodhouse CJ; Thompson A; Dudderidge T; Ogden C; Cooper CS; Lophatananon A; Cox A; Southey MC; Hopper JL; English DR; Aly M; Adolfsson J; Xu J; Zheng SL; Yeager M; Kaaks R; Diver WR; Gaudet MM; Stern MC; Corral R; Joshi AD; Shahabi A; Wahlfors T; Tammela TLJ; Auvinen A; Virtamo J; Klarskov P; Nordestgaard BG; Roder MA; Nielsen SF; Bojesen SE; Siddiq A; FitzGerald LM; Kolb S; Kwon EM; Karyadi DM; Blot WJ; Zheng W; Cai Q; McDonnell SK; Rinckleb AE; Drake B; Colditz G; Wokolorczyk D; Stephenson RA; Teerlink C; Muller H; Rothenbacher D; Sellers TA; Lin H-Y; Slavov C; Mitev V; Lose F; Srinivasan S; Maia S; Paulo P; Lange E; Cooney KA; Antoniou AC; Vincent D; Bacot F; Tessier DC; Kote-Jarai Z; Easton DF
Article: EUROPEAN UROLOGY. 2013;63(3):419-425
Prostate-specific Antigen (PSA) Testing Is Prevalent and Increasing in Stockholm County, Sweden, Despite No Recommendations for PSA Screening: Results from a Population-based Study, 2003-2011
Nordstrom T; Aly M; Clements MS; Weibull CE; Adolfsson J; Gronberg H
Article: HUMAN MOLECULAR GENETICS. 2013;22(2):408-415
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease
Al Olama AA; Kote-Jarai Z; Schumacher FR; Wiklund F; Berndt SI; Benlloch S; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Hunter DJ; Henderson BE; Thun MJ; Gaziano M; Giovannucci EL; Siddiq A; Travis RC; Cox DG; Canzian F; Riboli E; Key TJ; Andriole G; Albanes D; Hayes RB; Schleutker J; Auvinen A; Tammela TLJ; Weischer M; Stanford JL; Ostrander EA; Cybulski C; Lubinski J; Thibodeau SN; Schaid DJ; Sorensen KD; Batra J; Clements JA; Chambers S; Aitken J; Gardiner RA; Maier C; Vogel W; Doerk T; Brenner H; Habuchi T; Ingles S; John EM; Dickinson JL; Cannon-Albright L; Teixeira MR; Kaneva R; Zhang H-W; Lu Y-J; Park JY; Cooney KA; Muir KR; Leongamornlert DA; Saunders E; Tymrakiewicz M; Mahmud N; Guy M; Govindasami K; O'Brien LT; Wilkinson RA; Hall AL; Sawyer EJ; Dadaev T; Morrison J; Dearnaley DP; Horwich A; Huddart RA; Khoo VS; Parker CC; Van As N; Woodhouse CJ; Thompson A; Dudderidge T; Ogden C; Cooper CS; Lophatonanon A; Southey MC; Hopper JL; English D; Virtamo J; Le Marchand L; Campa D; Kaaks R; Lindstrom S; Diver WR; Gapstur S; Yeager M; Cox A; Stern MC; Corral R; Aly M; Isaacs W; Adolfsson J; Xu J; Zheng SL; Wahlfors T; Taari K; Kujala P; Klarskov P; Nordestgaard BG; Roder MA; Frikke-Schmidt R; Bojesen SE; FitzGerald LM; Kolb S; Kwon EM; Karyadi DM; Orntoft TF; Borre M; Rinckleb A; Luedeke M; Herkommer K; Meyer A; Serth J; Marthick JR; Patterson B; Wokolorczyk D; Spurdle A; Lose F; McDonnell SK; Joshi AD; Shahabi A; Pinto P; Santos J; Ray A; Sellers TA; Lin H-Y; Stephenson RA; Teerlink C; Muller H; Rothenbacher D; Tsuchiya N; Narita S; Cao G-W; Slavov C; Mitev V; Chanock S; Gronberg H; Haiman CA; Kraft P; Easton DF; Eeles RA
Article: NATURE GENETICS. 2011;43(8):785-U96
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
Kote-Jarai Z; Al Olama AA; Giles GG; Severi G; Schleutker J; Weischer M; Campa D; Riboli E; Key T; Gronberg H; Hunter DJ; Kraft P; Thun MJ; Ingles S; Chanock S; Albanes D; Hayes RB; Neal DE; Hamdy FC; Donovan JL; Pharoah P; Schumacher F; Henderson BE; Stanford JL; Ostrander EA; Sorensen KD; Dork T; Andriole G; Dickinson JL; Cybulski C; Lubinski J; Spurdle A; Clements JA; Chambers S; Aitken J; Gardiner RAF; Thibodeau SN; Schaid D; John EM; Maier C; Vogel W; Cooney KA; Park JY; Cannon-Albright L; Brenner H; Habuchi T; Zhang H-W; Lu Y-J; Kaneva R; Muir K; Benlloch S; Leongamornlert DA; Saunders EJ; Tymrakiewicz M; Mahmud N; Guy M; O'Brien LT; Wilkinson RA; Hall AL; Sawyer EJ; Dadaev T; Morrison J; Dearnaley DP; Horwich A; Huddart RA; Khoo VS; Parker CC; Van As N; Woodhouse CJ; Thompson A; Christmas T; Ogden C; Cooper CS; Lophatonanon A; Southey MC; Hopper JL; English DR; Wahlfors T; Tammela TLJ; Klarskov P; Nordestgaard BG; Roder MA; Tybjaerg-Hansen A; Bojesen SE; Travis R; Canzian F; Kaaks R; Wiklund F; Aly M; Lindstrom S; Diver WR; Gapstur S; Stern MC; Corral R; Virtamo J; Cox A; Haiman CA; Le Marchand L; FitzGerald L; Kolb S; Kwon EM; Karyadi DM; Orntoft TF; Borre M; Meyer A; Serth J; Yeager M; Berndt SI; Marthick JR; Patterson B; Wokolorczyk D; Batra J; Lose F; McDonnell SK; Joshi AD; Shahabi A; Rinckleb AE; Ray A; Sellers TA; Lin H-Y; Stephenson RA; Farnham J; Muller H; Rothenbacher D; Tsuchiya N; Narita S; Cao G-W; Slavov C; Mitev V; Easton DF; Eeles RA
Article: EUROPEAN UROLOGY. 2011;60(1):21-28
Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort Study
Aly M; Wiklund F; Xu J; Isaacs WB; Eklund M; D'Amato M; Adolfsson J; Gronberg H
Article: BMC MEDICAL GENOMICS. 2010;3:59
Birt-Hogg-Dube renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression
Klomp JA; Petillo D; Niemi NM; Dykema KJ; Chen J; Yang XJ; Saaf A; Zickert P; Aly M; Bergerheim U; Nordenskjold M; Gad S; Giraud S; Denoux Y; Yonneau L; Mejean A; Vasiliu V; Richard S; MacKeigan JP; Teh BT; Furge KA
Visa fler

Alla övriga publikationer

Letter: PATHOLOGY. 2024;56(7):1059-1061
Benign prostatic hyperplasia and insignificant prostate cancer with very high levels of serum prostate specific antigen
Samaratunga H; Delahunt B; Olsson M; Aly M; Egevad L; Yaxley J
Letter: SCANDINAVIAN JOURNAL OF UROLOGY. 2024;59:137-140
A population-based registry cohort study on the correlation between bladder- intact event-free survival and overall survival in cystectomy-ineligible/refusal muscle-invasive bladder cancer patients in Sweden
Laurin O; Baculea S; Cote S; Spigelman S; Szulkin R; Kwok KHM; Schain F; Jones CV; Aly M
Conference publication: JOURNAL OF UROLOGY. 2023;209:E997-E998
THE STOCKHOLM3 PROSTATE CANCER SCREENING TRIAL (STHLM3): AN INTERIM ANALYSIS OF MORTALITY RESULTS AFTER 6.5 YEARS OF FOLLOW-UP
Micoli C; Crippa A; Discacciati A; Palsdottir T; Vigneswaran H; Aly M; Adolfsson J; Lindberg J; Wiklund P; Thompson J; Brandberg Y; Clements M; Egevad L; Gronberg H; Nordstrom T; Eklund M
Conference publication: EUROPEAN UROLOGY. 2023;83:S208
The risk of arterial thromboembolic complications in bladder cancer patients after radical cystectomy - population-based nationwide matched cohort study
Rautiola J; Bjorklund J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Conference publication: EUROPEAN UROLOGY. 2023;83:S371
The risk of ischemic stroke and myocardial infarction in prostate cancer patients treated with radical prostatectomy - population-based nationwide matched cohort study
Rautiola J; Bjorklund J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Conference publication: JOURNAL OF UROLOGY. 2023;209:E214-E215
VALIDATION OF EAU RISK GROUPS FOR BIOCHEMICAL RECURRENCE AFTER RADIOTHERAPY AND RADICAL PROSTATECTOMY FOR PREDICTION OF PROSTATE CANCER MORTALITY
Falagario U; Bogdanovic D; Bjornebo L; Abbadi A; Valdman A; Eklund M; Nordstrom T; Aly M; Gronberg H; Lantz A; Wiklund P
Conference publication: JOURNAL OF UROLOGY. 2023;209:E419
PREDICTION OF PROSTATE CANCER SPECIFIC MORTALITY IN MEN UNDERGOING RADIOTHERAPY WITH OR WITHOUT HORMONAL TREATMENT, RISK STRATIFICATION BASED ON CLINICAL CHARACTERISTICS AND PSA TREATMENT RESPONSE
Falagario U; Bogdanovic D; Bjornebo L; Abbadi A; Valdman A; Eklund M; Nordstrom T; Aly M; Gronberg H; Wiklund P; Lantz A
Conference publication: EUROPEAN UROLOGY. 2023;83:S369-S370
The risk of venous thromboembolic events among men operated with radical prostatectomy - A nationwide population-based cohort study
Bjorklund J; Rautiola J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Conference publication: EUROPEAN UROLOGY. 2023;83:S379-S380
Validation of EAU Risk groups for biochemical recurrence after radiotherapy and radical prostatectomy for prediction of prostate cancer mortality
Falagario UG; Bogdanovic D; Bjornebo L; Abbadi A; Valdman A; Eklund M; Nordstrom T; Aly M; Gronberg H; Lantz A; Wiklund P
Conference publication: EUROPEAN UROLOGY. 2023;83:S209-S210
The risk of Venous thromboembolic events in patients operated with radical cystectomy - a nationwide population-based cohort study
Bjorklund J; Rautiola J; Zelic R; Vincent PH; Wiklund P; Aly M; Akre O
Conference publication: EUROPEAN UROLOGY. 2022;81:S792-S793
Disease trajectories and outcomes for men with castration resistant prostate cancer by use of nation-wide population-based observational data
Ventimiglia E; Bill-Axelson A; Aly M; Eklund M; Stattin P; Garmo H
Conference publication: EUROPEAN UROLOGY. 2022;81:S561-S562
Long-term effects of 5α-reductase inhibitors on prostate cancer mortality: A large population-based prospective study
Bjornebo L; Nordstrom T; Discacciati A; Palsdottir T; Aly M; Gronberg H; Eklund M; Lantz A
Editorial comment: JOURNAL OF UROLOGY. 2022;207(1):231
Re: MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
Eklund M; Jaderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Gronberg H; Nordstrom T
Conference publication: JOURNAL OF UROLOGY. 2022;207(5):E41
LONG-TERM EFFECTS OF 5A-REDUCTASE INHIBITORS ON PROSTATE CANCER MORTALITY - A LARGE POPULATION-BASED PROSPECTIVE STUDY
Bjornebo L; Nordstrom T; Discacciati A; Palsdottir T; Aly M; Gronberg H; Eklund M; Lantz A
Corrigendum: NATURE GENETICS. 2021;53(3):413
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (vol 53, pg 65, 2021)
Conti DV; Darst BF; Moss LC; Saunders EJ; Sheng X; Chou A; Schumacher FR; Al Olama AA; Benlloch S; Dadaev T; Brook MN; Sahimi A; Hoffmann TJ; Takahashi A; Matsuda K; Momozawa Y; Fujita M; Muir K; Lophatananon A; Wan P; Le Marchand L; Wilkens LR; Stevens VL; Gapstur SM; Carter BD; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Giles GG; Southey MC; MacInnis RJ; Cybulski C; Wokolorczyk D; Lubinski J; Neal DE; Donovan JL; Hamdy FC; Martin RM; Nordestgaard BG; Nielsen SF; Weischer M; Bojesen SE; Roder MA; Iversen P; Batra J; Chambers S; Moya L; Horvath L; Clements JA; Tilley W; Risbridger GP; Gronberg H; Aly M; Szulkin R; Eklund M; Nordstrom T; Pashayan N; Dunning AM; Ghoussaini M; Travis RC; Key TJ; Riboli E; Park JY; Sellers TA; Lin H-Y; Albanes D; Weinstein SJ; Mucci LA; Giovannucci E; Lindstrom S; Kraft P; Hunter DJ; Penney KL; Turman C; Tangen CM; Goodman PJ; Thompson IMJ; Hamilton RJ; Fleshner NE; Finelli A; Parent M-E; Stanford JL; Ostrander EA; Geybels MS; Koutros S; Freeman LEB; Stampfer M; Wolk A; Hakansson N; Andriole GL; Hoover RN; Machiela MJ; Sorensen KD; Borre M; Blot WJ; Zheng W; Yeboah ED; Mensah JE; Lu Y-J; Zhang H-W; Feng N; Mao X; Wu Y; Zhao S-C; Sun Z; Thibodeau SN; McDonnell SK; Schaid DJ; West CML; Burnet N; Barnett G; Maier C; Schnoeller T; Luedeke M; Kibel AS; Drake BF; Cussenot O; Cancel-Tassin G; Menegaux F; Truong T; Koudou YA; John EM; Grindedal EM; Maehle L; Khaw K-T; Ingles SA; Stern MC; Vega A; Gomez-Caamano A; Fachal L; Rosenstein BS; Kerns SL; Ostrer H; Teixeira MR; Paulo P; Brandao A; Watya S; Lubwama A; Bensen JT; Fontham ETH; Mohler J; Taylor JA; Kogevinas M; Llorca J; Castano-Vinyals G; Cannon-Albright L; Teerlink CC; Huff CD; Strom SS; Multigner L; Blanchet P; Brureau L; Kaneva R; Slavov C; Mitev V; Leach RJ; Weaver B; Brenner H; Cuk K; Holleczek B; Saum K-U; Klein EA; Hsing AW; Kittles RA; Murphy AB; Logothetis CJ; Kim J; Neuhausen SL; Steele L; Ding YC; Isaacs WB; Nemesure B; Hennis AJM; Carpten J; Pandha H; Michael A; De Ruyck K; De Meerleer G; Ost P; Xu J; Razack A; Lim J; Teo S-H; Newcomb LF; Lin DW; Fowke JH; Neslund-Dudas C; Rybicki BA; Gamulin M; Lessel D; Kulis T; Usmani N; Singhal S; Parliament M; Claessens F; Joniau S; Van den Broeck T; Gago-Dominguez M; Castelao JE; Martinez ME; Larkin S; Townsend PA; Aukim-Hastie C; Bush WS; Aldrich MC; Crawford DC; Srivastava S; Cullen JC; Petrovics G; Casey G; Roobol MJ; Jenster G; van Schaik RHN; Hu JJ; Sanderson M; Varma R; McKean-Cowdin R; Torres M; Mancuso N; Berndt SI; Van den Eeden SK; Easton DF; Chanock SJ; Cook MB; Wiklund F; Nakagawa H; Witte JS; Eeles RA; Kote-Jarai Z; Haiman CA
Conference publication: EUROPEAN UROLOGY. 2021;79:S1429
Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, magnetic resonance imaging and targeted prostate biopsies: The STHLM3MRI trial
Nordstrom T; Discacciati A; Bergman M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jaderling F; Eklund M; Gronberg H
Conference publication: EUROPEAN UROLOGY. 2021;79:S1430
MRI-targeted or systematic biopsies in prostate cancer screening: The STHLM3MRI trial
Eklund M; Jaderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Gronberg H; Nordstrom T
Preprint: SSRN ELECTRONIC JOURNAL. 2021
Prostate Cancer Screening Using a Combination of Risk-Prediction, Magnetic Resonance Imaging and Targeted Prostate Biopsies: A Randomised Trial
Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H
Conference publication: JOURNAL OF UROLOGY. 2020;203:E247-E248
REAL-WORLD TREATMENT PATTERNS IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER
Vigneswaran HT; Warnqvist A; Andersson TML; Leval A; Schain F; Liwing J; Eloranta S; Pettersson A; Akre O; Aly M
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6)
MRI-targeted biopsies in prostate cancer screening and the value of its combination with blood-based risk-prediction: The randomized, diagnostic study STHLM3MRI
Nordstrom T; Discacciati A; Jaderling F; Karlsson SG; Aly M; Gronberg H; Eklund M
Review: EUROPEAN UROLOGY FOCUS. 2019;5(5):788-798
Time-to-event Outcomes in Men with Nonmetastatic Castrate-resistant Prostate Cancer-A Systematic Literature Review and Pooling of Individual Participant Data
Aly M; Hashim M; Heeg B; Liwing J; Leval A; Mehra M; Lawson J; Brookman-May SD; Akre O
Preprint: BIORXIV. 2019
The effect of sample size on polygenic hazard models for prostate cancer
Karunamuni RA; Huynh-Le M-P; Fan CC; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; Gronberg H; Wiklund F; Aly M; Schleutker J; Sipeky C; Tammela TL; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Schöttker B; Holleczek B; Park JY; Sellers TA; Lin H-Y; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; BioResource APC; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Mills IG; Andreassen OA; Dale AM; Seibert TM; Consortium TP
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(15):e16555
Survival in men diagnosed with castration resistant prostate cancer: A population-based observational study in Sweden.
Aly M; Schain F; Leval A; Liwing J; Lawson J; Vago E; Nordstrom T; Gronberg H; Andersson TM-L; Sjoland E; Wang C; Eloranta S; Akre O
Preprint: BIORXIV. 2019
A genetic hazard score to personalize prostate cancer screening, applied to population data
Huynh-Le M-P; Fan CC; Karunamuni R; Walsh EI; Turner EL; Lane JA; Martin RM; Neal DE; Donovan JL; Hamdy FC; Parsons JK; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; Gronberg H; Wiklund F; Aly M; Schleutker J; Sipeky C; Tammela TL; Nordestgaard BG; Key TJ; Travis RC; Pharoah P; Pashayan N; Khaw K-T; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Schöttker B; Holleczek B; Park JY; Sellers TA; Lin H-Y; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; BioResource APC; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Mills IG; Andreassen OA; Dale AM; Seibert TM; Consortium TP
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2019;133:S824-S825
Postoperative radiation therapy following radical prostatectomy in Stockholm County in 2008-2016
Falk J; Aly M; Nordstrom T; Valdman A
Corrigendum: NATURE GENETICS. 2019;51(2):363
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (vol 50, pg 928, 2018)
Schumacher FR; Al Olama AA; Berndt SI; Benlloch S; Ahmed M; Saunders EJ; Dadaev T; Leongamornlert D; Anokian E; Cieza-Borrella C; Goh C; Brook MN; Sheng X; Fachal L; Dennis J; Tyrer J; Muir K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman PJ; Thompson IMJ; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger GP; Gronberg H; Aly M; Nordstrom T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Hakansson N; West CML; Dunning AM; Burnet N; Mucci LA; Giovannucci E; Andriole GL; Cussenot O; Cancel-Tassin G; Koutros S; Freeman LEB; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein BS; Kerns SL; Ostrer H; Lu Y-J; Zhang H-W; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gomez-Caamano A; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castano-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin H-Y; Stanford JL; Cybulski C; Wokolorczyk D; Lubinski J; Ostrander EA; Geybels MS; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Roder MA; Iversen P; Brenner H; Cuk K; Holleczek B; Maier C; Luedeke M; Schnoeller T; Kim J; Logothetis CJ; John EM; Teixeira MR; Paulo P; Cardoso M; Neuhausen SL; Steele L; Ding YC; De Ruyck K; De Meerleer G; Ost P; Razack A; Lim J; Teo S-H; Lin DW; Newcomb LF; Lessel D; Gamulin M; Kulis T; Kaneva R; Usmani N; Singhal S; Slavov C; Mitev V; Parliament M; Claessens F; Joniau S; Van den Broeck T; Larkin S; Townsend PA; Aukim-Hastie C; Gago-Dominguez M; Castelao JE; Martinez ME; Roobol MJ; Jenster G; van Schaik RHN; Menegaux F; Truong T; Koudou YA; Xu J; Khaw K-T; Cannon-Albright L; Pandha H; Michael A; Thibodeau SN; McDonnell SK; Schaid DJ; Lindstrom S; Turman C; Ma J; Hunter DJ; Riboli E; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Cui Z; Kraft P; Amos CI; Conti DV; Easton DF; Wiklund F; Chanock SJ; Henderson BE; Kote-Jarai Z; Haiman CA; Eeles RA
Corrigendum: NATURE COMMUNICATIONS. 2019;10(1):382
Germline variation at 8q24 and prostate cancer risk in men of European ancestry (vol 9, 4616, 2018)
Matejcic M; Saunders EJ; Dadaev T; Brook MN; Wang K; Sheng X; Al Olama AA; Schumacher FR; Ingles SA; Govindasami K; Benlloch S; Berndt SI; Albanes D; Koutros S; Muir K; Stevens VL; Gapstur SM; Tangen CM; Batra J; Clements J; Gronberg H; Pashayan N; Schleutker J; Wolk A; West C; Mucci L; Kraft P; Cancel-Tassin G; Sorensen KD; Maehle L; Grindedal EM; Strom SS; Neal DE; Hamdy FC; Donovan JL; Travis RC; Hamilton RJ; Rosenstein B; Lu Y-J; Giles GG; Kibel AS; Vega A; Bensen JT; Kogevinas M; Penney KL; Park JY; Stanford JL; Cybulski C; Nordestgaard BG; Brenner H; Maier C; Kim J; Teixeira MR; Neuhausen SL; De Ruyck K; Razack A; Newcomb LF; Lessel D; Kaneva R; Usmani N; Claessens F; Townsend PA; Gago-Dominguez M; Roobol MJ; Menegaux F; Khaw K-T; Cannon-Albright LA; Pandha H; Thibodeau SN; Schaid DJ; Wiklund F; Chanock SJ; Easton DF; Eeles RA; Kote-Jarai Z; Conti DV; Haiman CA; Henderson BE; Stern MC; Thwaites A; Guy M; Whitmore I; Morgan A; Fisher C; Hazel S; Livni N; Cook M; Fachal L; Weinstein S; Freeman LEB; Hoover RN; Machiela MJ; Lophatananon A; Carter BD; Goodman P; Moya L; Srinivasan S; Kedda M-A; Yeadon T; Eckert A; Eklund M; Cavalli-Bjoerkman C; Dunning AM; Sipeky C; Hakansson N; Elliott R; Ranu H; Giovannucci E; Turman C; Hunter DJ; Cussenot O; Orntoft TF; Lane A; Lewis SJ; Davis M; Key TJ; Brown P; Kulkarni GS; Zlotta AR; Fleshner NE; Finelli A; Mao X; Marzec J; MacInnis RJ; Milne R; Hopper JL; Aguado M; Bustamante M; Castano-Vinyals G; Gracia-Lavedan E; Cecchini L; Stampfer M; Ma J; Sellers TA; Geybels MS; Park H; Zachariah B; Kolb S; Wokolorczyk D; Lubinski J; Kluzniak W; Nielsen SF; Weisher M; Cuk K; Vogel W; Luedeke M; Logothetis CJ; Paulo P; Cardoso M; Maia S; Silva MP; Steele L; Ding YC; De Meerleer G; De Langhe S; Thierens H; Lim J; Tan MH; Ong AT; Lin DW; Kachakova D; Mitkova A; Mitev V; Parliament M; Jenster G; Bangma C; Schroder FH; Truong T; Koudou YA; Michael A; Kierzek A; Karlsson A; Broms M; Wu H; Aukim-Hastie C; Tillmans L; Riska S; McDonnell SK; Dearnaley D; Spurdle A; Gardiner R; Hayes V; Butler L; Taylor R; Papargiris M; Saunders P; Kujala P; Talala K; Taari K; Bentzen S; Hicks B; Vogt A; Hutchinson A; Cox A; George A; Toi A; Evans A; van der Kwast TH; Imai T; Saito S; Zhao S-C; Ren G; Zhang Y; Yu Y; Wu Y; Wu J; Zhou B; Pedersen J; Lobato-Busto R; Manuel Ruiz-Dominguez J; Mengual L; Alcaraz A; Pow-Sang J; Herkommer K; Vlahova A; Dikov T; Christova S; Carracedo A; Tretarre B; Rebillard X; Mulot C; Adolfsson J; Stattin P; Johansson J-E; Martin RM; Thompson IMJ; Chambers S; Aitken J; Horvath L; Haynes A-M; Tilley W; Risbridger G; Aly M; Nordstrom T; Pharoah P; Tammela TLJ; Murtola T; Auvinen A; Burnet N; Barnett G; Andriole G; Klim A; Drake BF; Borre M; Kerns S; Ostrer H; Zhang H-W; Cao G; Lin J; Ling J; Li M; Feng N; Li J; He W; Guo X; Sun Z; Wang G; Guo J; Southey MC; FitzGerald LM; Marsden G; Gomez-Caamano A; Carballo A; Peleteiro P; Calvo P; Szulkin R; Llorca J; Dierssen-Sotos T; Gomez-Acebo I; Lin H-Y; Ostrander EA; Bisbjerg R; Klarskov P; Roder MA; Iversen P; Holleczek B; Stegmaier C; Schnoeller T; Bohnert P; John EM; Ost P; Teo S-H; Gamulin M; Kulis T; Kastelan Z; Slavov C; Popov E; Van den Broeck T; Joniau S; Larkin S; Esteban Castelao J; Martinez ME; van Schaik RHN; Xu J; Lindstrom S; Riboli E; Berry C; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Freedman M; Cenee S; Sanchez M
Editorial comment: EUROPEAN UROLOGY FOCUS. 2017;3(6):526-528
Detection of Prostate Cancer Using a Multistep Approach with Prostate-specific Antigen, the Stockholm 3 Test, and Targeted Biopsies: The STHLM3 MRI Project
Nordstrom T; Picker W; Aly M; Jaderling F; Adolfsson J; Strom P; Haug ES; Eklund M; Carlsson S; Gronberg H
Other: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2017;35(3):120
Prostate cancer screening in men aged 50 to 69 years (STHLM3): A prospective population-based diagnostic study. Grönberg H, Adolfsson J, Aly M, Nordström T, Wiklund P, Brandberg Y, Thompson J, Wiklund F, Lindberg J, Clements M, Egevad L, Eklund M.Lancet Oncol. 2015 Dec;16(16):1667-76. [Epub 2015 Nov 10]. doi: 10.1016/S1470-2045(15)00361-7.
Scott E; Adolfsson J; Aly M; Nordström T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Preprint: BIORXIV. 2016
A genetic risk score to guide age-specific, personalized prostate cancer screening
Seibert TM; Fan CC; Wang Y; Zuber V; Karunamuni R; Parsons JK; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; Gronberg H; Wiklund F; Aly M; Schleutker J; Sipeky C; Tammela TL; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Røder MA; Iversen P; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Cuk K; Saum K-U; Park JY; Sellers TA; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; BioResource APC; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Karow DS; Mills IG; Andreassen OA; Dale AM; consortium TP
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(2):36
The risk-based STHLM3 model to improve prostate cancer testing in men 50-69 years: Further health, economic, and clinic evaluation
Gronberg H; Adolfsson J; Aly M; Nordstrom T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Thesis / dissertation: 2014
Prostate cancer diagnostics : complications and ways to reduce unnecessary biopsies
Aly, Markus
Review: ACTA ONCOLOGICA. 2011;50:18-23
Early detection of prostate cancer with emphasis on genetic markers
Aly M; Wiklund F; Gronberg H
Visa fler

Anställningar

Anknuten till Forskning, Molekylär medicin och kirurgi, Karolinska Institutet, 2024-2026

Examina och utbildning

Docent, Urologi, Karolinska Institutet, 2024
Medicine Doktorsexamen, Institutionen för kliniska vetenskaper, Danderyds sjukhus, Karolinska Institutet, 2015
Läkarexamen, Karolinska Institutet, 2003

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI